Stem Cell Transplantation for Newly Diagnosed M/M
Dara-KRd, Autologous Transplantation, and MRD Response-Adapted Consolidation and Treatment Cessation in NDMM: Final Primary Endpoint Analysis of the MASTER Trial
Login to view comments.
Click here to Login
